An Explorative Investigation to Study the Relationship and Distribution of Neutrophils in Bronchial Mucosal Tissue, Induced Sputum and Blood After Administration of 45 mg BD AZD 5069 for 4 Weeks to Patients With Moderate Persistent Neutrophilic Asthma
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs AZD 5069 (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 17 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Jun 2014 Planned End Date changed from 1 Jul 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
- 23 Jun 2014 Planned primary completion date changed from 1 Jul 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.